• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sens Biosensing Res. Rapid multiplex microfiber-based immunoassay for anti-MERS-CoV antibody detection

tetano

Editor, Senior Moderator
Sens Biosensing Res. 2019 Nov;26:100304. doi: 10.1016/j.sbsr.2019.100304. Epub 2019 Oct 14.
Rapid multiplex microfiber-based immunoassay for anti-MERS-CoV antibody detection.


Hoy CFO[SUP]1[/SUP], Kushiro K[SUP]1[/SUP], Yamaoka Y[SUP]2,[/SUP][SUP]3[/SUP], Ryo A[SUP]2[/SUP], Takai M[SUP]1[/SUP].

Author information




Abstract

On-site multiplex biosensors for innate immunity antibodies are ideal tools for monitoring health status of individuals against various diseases. This study introduces a novel antibody immunoassay testing platform incorporating microfiber-based arrays of antigens to capture specific antibodies. The fabrication and setup of the device revolved around electrospun polystyrene (ESPS) microfibers that act as three-dimensional membrane filters, capable of rapid and multifold analyte capture. In particular, the ESPS microfibers were patterned through localized oxygen plasma to create hydrophilic zones that facilitate fluid flows and immobilizations of antigens. The bulk of this robust antibody immunoassay platform could be installed into a compact syringe-driven cassette device, which could perform multiplex antibody immunoassay for antibodies specifically against Middle East respiratory syndrome coronavirus (MERS-CoV) with rapid preparation amounting to a total of 5 min, as well as high sensitivity and specificity for the MERS-CoV down to 200 μg/mL.
? 2019 The Authors.



KEYWORDS:

MERS; Microfiber; Multiplex immunoassay; POC; Rapid


PMID:32289017PMCID:PMC7104066DOI:10.1016/j.sbsr.2019.100304
 
Back
Top